Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

New guidelines help interventional cardiologists manage chronic venous disease
"These recommendations will help ensure that patient care remains both consistent and personalized," SCAI President Srihari S. Naidu, MD, explained.
Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
New report raises questions about data that helped heart drug gain FDA approval
Ticagrelor, an antiplatelet medication from AstraZeneca commonly prescribed by cardiologists, gained FDA approval back in 2011. The author of a new investigative report, however, is raising several concerns about the data used to secure that approval.
Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease
Semaglutide, tirzepatide and other GLP-1 drugs appear to provide significant value for patients with moderate PAD.
Angiographic catheters recalled due to safety risk
The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use.

E-cigarette use causes as much vascular damage as smoking cigarettes

E-cigarettes can cause just as much damage to a person’s arteries and blood vessels as traditional cigarettes, according to a new study published in the Journal of the American Heart Association.

Another way work-related stress can impact your cardiovascular health

Work-related stress is associated with an increased risk of peripheral artery disease (PAD), according to a new study published in the Journal of the American Heart Association.

New research highlights the connection between venous thromboembolism and COVID-19

Hospitalized COVID-19 patients experience a high rate of thromboembolic complications, according to new findings published in Thrombosis Research.

Even later in life, lifestyle changes can help women reduce risk of stroke

Some middle-aged women may think they have waited too long to reduce their risk of stroke by adopting a healthier lifestyle—that it is too late for such a change to make an impact.

Stroke surgeons issue warning to public: Time is still brain during COVID-19 pandemic

The COVID-19 pandemic is changing patient care at hospitals all over the world, but a group of leading surgeons wants to make sure people aren’t ignoring stroke symptoms due to fears over getting the virus.

Cardiac injury in COVID-19 patients associated with higher in-hospital mortality

Cardiac injury is common among patients hospitalized with COVID-19, according to new research out of Wuhan, China. The study, published in JAMA Cardiology, also found that cardiac injuries were associated with an increased risk of in-hospital mortality.

Abdominal stent graft solution from Endologix gains FDA approval

Endologix, an Irvine, California-based healthcare technology company, has received FDA approval for its new abdominal stent graft solution.

Risk of death from stroke drops 24%

The primary reason behind this change is believed to be significant improvements in how healthcare providers care for stroke patients.

Vascular & Endovascular

New guidelines help interventional cardiologists manage chronic venous disease

Private equity firm jumps into vascular health with new investment

New report raises questions about data that helped heart drug gain FDA approval

Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease

Angiographic catheters recalled due to safety risk